The role of GALNT14-rs9679162 in predicting therapeutic outcomes was initially established in advanced hepatocellular carcinoma (HCC) patients receiving chemotherapies [10,12,16]. The gene discussed is GALNT14; the disease is hepatocellular carcinoma.